ePRO Resources

  1. ePROM Implementation: 4 Best Practices For System Functionality 2/13/2024

    Explore four of the 15 system functionality considerations highlighted in an eCOA Consortium article that aim to create a more thorough and standardized approach to ePROM implementation.

  2. Create Personalized Treatments With VR And RWD 5/13/2023

    Dive into the ways this cutting-edge technology is revolutionizing how healthcare providers create personalized treatment plans for patients suffering from chronic low back pain (CLBP).

  3. Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials 6/23/2022

    This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.

  4. NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO 3/20/2023

    Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.

  5. Ensuring Patient-Centered Care In Oncology Trials 11/10/2023

    In oncology trials, safety and tolerability are a core focus. From centralized ECGs to patient-reported outcomes, utilize this guide for optimizing assessments of drug safety and quality of life.

  6. Pharmaceutical Company Gets Unified Decentralized Platform 2/28/2023

    Unearth how this global eClinical provider delivered a decentralized platform including eSource/ePRO for direct-data-entry, randomization, eConsent, telehealth, remote monitoring, and data management.

  7. Simplify Today. Transform For The Future. 10/25/2023

    Maximize efficiency today with a cloud-based user-friendly platform that seamlessly adapts to the future of phase 1-3 trials. Watch to see how Zelta can help.

  8. Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC 2/23/2023

    Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

  9. FDA's Vision On PRO Collection For RWE 9/24/2024

    In this presentation, a distinguished panel of experts illuminates the crucial role of patient-reported outcomes (PROs) in shaping regulatory decisions and drug development strategies.

  10. Why Capturing Pro Data Matters In Early-Phase Oncology Trials 9/26/2024

    If you are in the early stages of an oncology trial, there is a lot to consider when it comes to your data management and how the process can be simplified by improving how your study captures data.